Lynne Marie Sullivan

CIK 1727640 · CFO & Head of Corp. Dev. · last filed 2026-06-11

Lynne Marie Sullivan is a CFO & Head of Corp. Dev. who has filed 37 SEC Form 4 insider transactions across 5 companies since 2018. The most recent filing, for SLDB, was dated Jun 11, 2026. Across all open-market trades the lifetime net is +$26.3K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

37

Lifetime Open-Market Net

$26.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SLDB Director $7.14 $0 11 2026-06-11
Unity Biotechnology, Inc. (UBX) Delisted CFO & Head of Corp. Dev. 98,905 $0.20 $19.8K -$23.7K 13 2025-04-03
Inozyme Pharma, Inc. (INZY) Delisted Director $4.00 $0 5 2024-06-20
BiomX Inc. (PHGE.WS) Delisted Director 12,500 $0.01 $110 $50.0K 5 2023-03-03
Adicet Bio, Inc. (TORC) Delisted Director $0 2 2020-06-05

Recent Filings

37 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-11 SLDB Grant (A) $0 EDGAR
2025-07-03 Disp (D) $0
2025-06-13 SLDB Grant (A) $0 EDGAR
2025-04-03 Unity Biotechnology, Inc. (UBX) Delisted Sell (S) −21,867 -$22.5K EDGAR
2025-03-31 Unity Biotechnology, Inc. (UBX) Delisted Grant (A) +65,000 $0 EDGAR
2025-02-05 Unity Biotechnology, Inc. (UBX) Delisted Sell (S) −153 -$341 EDGAR
2025-01-23 Unity Biotechnology, Inc. (UBX) Delisted Grant (A) $0 EDGAR
2024-11-06 Unity Biotechnology, Inc. (UBX) Delisted Sell (S) −136 -$175 EDGAR
2024-08-06 Unity Biotechnology, Inc. (UBX) Delisted Sell (S) −139 -$213 EDGAR
2024-06-26 Unity Biotechnology, Inc. (UBX) Delisted Sell (S) −324 -$454 EDGAR
Showing 110 of 37
Page 1 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.